Roche actually took over Genentech which have 4 major drugs at the time, one being Herceptin. And guess who worked at Genentech at the time? Our very own CEO Leslie Chong.
So as you can see, Leslie Chong is a very experienced operator in this field. She has successfully bring 4 drugs from bench to bedside. That is one invaluable experience that is very rare in Australia. For IMU to have her at the helm, we as shareholders are truly blessed. And so will potential patients of the future.
-
- There are more pages in this discussion • 3,262 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.2¢ | $267.3K | 20.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 788815 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 13241534 | 29 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |